Similar Items: Clinically Amyopathic Dermatomyositis: Epidemiology, Clinical Presentation, Pathophysiology, Treatment, and Prognosis: A Systematic Review
- Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
- Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers
- Demographic and clinical characteristics of children with juvenile dermatomyositis in Cape Town
- Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Subcutaneous Emphysema and Severe Interstitial Lung Disease in the Setting of Anti-MDA 5 Positive Dermatomyositis in a Hispanic Patient